Author Affiliations: Division of Cardiovascular Medicine, Gill Heart Institute, and Department of Statistics, University of Kentucky, Lexington.
Published online March 13, 2006 (doi:10.1001/jama.295.13.jed60017).
Worldwide, more than 2 million patients will be treated with a percutaneous coronary intervention (PCI) this year, with approximately half of these performed in the United States.1 For almost three fourths of these patients, the diagnosis necessitating the procedure will be an acute coronary syndrome (ACS)—either unstable angina or a myocardial infarction (MI).2
Steinhubl SR, Charnigo R. Clopidogrel Treatment Prior to Percutaneous Coronary InterventionWhen Enough Isn't Enough. JAMA. 2006;295(13):1581-1582. doi:10.1001/jama.295.13.jed60017